BioVie (BIVI) is scheduled to report Q4 earnings on August 14, 2026.
In the most recent quarter (Q3), BioVie reported EPS of $-0.70, beating estimates of $-0.73 by 0.04%. Revenue came in at $0, meeting the estimate of $0 by 0.00%.
BioVie has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, BioVie has averaged an EPS surprise of 0.25% and a revenue surprise of 0.00%.
Analyze the earnings history of BioVie using advanced sorting and filters.
The chart below shows BioVie's reported EPS compared to analyst estimates over recent quarters.
The chart below shows BioVie's reported revenue compared to analyst estimates over recent quarters.
BioVie (BIVI) is scheduled to report earnings on August 14, 2026. The last reported earnings were for reported on May 11, 2026 for Q3.
The Actual EPS was $-0.70, which beat the estimate of $-0.73.
The Actual Revenue was $0, which hit the estimate of $0.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2026-05-11 | $-0.70 | $-0.73 | 4.11 % |
| Q2 | 2026-02-06 | $-0.77 | $-0.81 | 4.94 % |
| Q1 | 2025-11-10 | $-0.98 | $-0.79 | -24.1 % |
| Q4 | 2025-08-15 | $-1.42 | $-4.40 | 67.7 % |